The Potential of Resistant Starch in Combating Fatty Liver Disease

A four-month randomized controlled trial involving 200 patients with non-alcoholic fatty liver disease (NAFLD) found that daily intake of resistant starch, a non-digestible fiber, can alter gut bacteria composition and reduce liver triglycerides and liver enzymes associated with liver injury and inflammation. Participants who received the resistant starch treatment had nearly 40% lower liver triglyceride levels compared to the control group, and these benefits were independent of weight loss. The study suggests that resistant starch could be an effective and affordable intervention for managing NAFLD.